Impact of hypoxia on IGF-I, IGF-II, IGFBP-3, ALS and IGFBP-1 regulation and on IGF1R gene expression in children

Growth Hormone and IGF Research

Volumn 22, Issue 5, 2012, Pages 186-191

  Custodio, Rodrigo José ^a   do Carmo Custodio, Viviane Imaculada ^a   Scrideli, Carlos Alberto ^a   Sader Milani, Soraya Lopes ^a   Cervi, Maria Célia ^a   Cupo, Palmira ^a   Martinelli, Carlos Eduardo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ALS; Children; Gene expression; GH; Hypoxia; IGF I; IGF II; IGF1R; IGFBP 1; IGFBP 3

Indexed keywords

GROWTH HORMONE; INSULIN; INSULIN LIKE GROWTH FACTOR 3; MESSENGER RNA; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROIMMUNOASSAY; GENE EXPRESSION REGULATION; HUMAN; HYPOXIA; INFANT; INSULIN LIKE GROWTH FACTOR 1 RECEPTOR GENE; MALE; NEWBORN; NEWBORN HYPOXIA; OXYGEN SATURATION; PATIENT ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PULSE OXIMETRY; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; RESPIRATORY DISTRESS; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; UPREGULATION;

CELL HYPOXIA; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFANT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; REAL-TIME POLYMERASE CHAIN REACTION; SOMATOMEDINS; UP-REGULATION;

EID: 84865363609     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2012.07.001     Document Type: Article

References (42)

1. Thissen J.P., Ketelslegers J.M., Underwood L.E. Nutritional regulation of the insulin-like growth factors. Endocr. Rev. 1994, 15:80-101.
2. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 1995, 16:3-34.
3. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm. IGF Res. 2003, 13:113-170.
4. Rudman D., Kutner M.H., Rogers C.M., Lubin M.F., Fleming G.A., Bain R.P. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J. Clin. Invest. 1981, 67:1361-1367.
5. Bouhaddioui L., Brun J.F., Jacquemin J.L., et al. Immunoreactive somatomedin C in children from Morocco: a biological marker of nutritional growth retardation?. Biomed. Pharmacother. 1989, 43:59-63.
6. Blum W.F., Albertsson-Wikland K., Rosberg S., Rank M.B. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J. Clin. Endocrinol. Metab. 1993, 76:1610-1616.
7. Rechler M.M., Nissley S.P. The nature and regulation of the receptor for insulin-like growth factors. Annu. Rev. Physiol. 1985, 47:425-442.
8. Neely E.K., Beukers M.W., Oh Y., Cohen P., Rosenfeld R.G. Insulin-like growth factors receptors. Acta Paediatr. Scand. Supp. 1991, 372:116-123.
9. LeRoith D., Werner H., Beitner-Johnson D., Roberts C.T. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 1995, 16:143-163.
10. Povoa G., Enberg G., Jörnvall H., Hall K. Isolation and characterization of somatomedin-binding protein from midterm human amniotic fluid. Eur. J. Biochem. 1984, 144:199-204.
11. Coterril A.M., Cowell C.T., Baxter R.C., McNeil D., Silinik M. Regulation of the growth hormone-independent growth factor-binding protein in children. J. Clin. Endocrinol. Metab. 1988, 67:882-887.
12. Holly J.P.M., Dunger D.B., Edge J.A., Smith C.P., Chard T., Wass J.A. Insulin-like growth factor binding protein-1 levels in diabetic adolescents and their relationship to metabolic control. Diabet. Med. 1990, 7:618-623.
13. Jones J.I., D'Ercole A.J., Camacho-Hübner C., Clemmons D.R. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:7481-7485.
14. Brismar K., Fernqvist-Forbes E., Wahren J., Hall K. Effect of insulin on the hepatic production of insulin-like growth factor binding protein-1 (IGFBP-1), IGFBP-3 and IGF-I in insulin-dependent diabetes. J. Clin. Endocrinol. Metab. 1994, 79:872-878.
15. Mohan S., Baylink D.J. IGF-binding proteins are multifunctional and act via IGF-dependent and independent mechanisms. J. Endocrinol. 2002, 175:19-31.
16. Giudice L.C., Zegher F., Gargosky S.E., et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J. Clin. Endocrinol. Metab. 1995, 80:1548-1555.
17. McLellan K.C., Hooper S.B., Bocking A.D., et al. Prolonged hypoxia induced by the reduction of maternal uterine blood flow alters insulin-like growth factor-binding protein-1 (IGFBP-1) and IGFBP-2 gene expression in the ovine fetus. Endocrinology 1992, 131:1619-1628.
18. Tapanainen P.J., Bang P., Wilson K., Unterman T.G., Vreman H.J., Rosenfeld R.G. Maternal hypoxia as a model for intrauterine growth retardation: effects on insulin-like growth factors and their binding proteins. Pediatr. Res. 1994, 36:152-158.
19. Popovici R.M., Lu M., Bhatia S., Faessen G.H., Giaccia A.J., Giudice L.C. Hypoxia regulates insulin-like growth factor-binding protein 1 in human fetal hepatocytes in primary culture: suggestive molecular mechanisms for in utero fetal growth restriction caused by uteroplacental insufficiency. J. Clin. Endocrinol. Metab. 2001, 86:2653-2659.
20. Morgan B.L.G., Chao C.R. The effects of hypoxia on growth cones in the ovine fetal brain. J. Matern. Fetal Neonatal Med. 2004, 16:55-59.
21. δδCT method. Methods 2001, 25:402-408.
22. Bhatia S., Faessen G.H., Carland G., et al. A longitudinal analysis of maternal serum insulin-like growth factor I (IGF-I) and total and nonphosphorylated IGF-binding protein-1 in human pregnancies complicated by intrauterine growth restriction. J. Clin. Endocrinol. Metab. 2002, 87:1864-1870.
23. Roig M.D., Sabrià J., Valls C., et al. The use of biochemical markers in prenatal diagnosis of intrauterine growth retardation: insulin-like growth factor I, Leptin, and alpha-fetoprotein. Eur. J. Obstet. Gynecol. Reprod. Biol. 2005, 120:27-32.
24. Dündar B., Akçoral A., Saylam G., et al. Chronic hypoxemia leads to reduced serum IGF-I levels in cyanotic congenital heart disease. J. Pediatr. Endocrinol. Metab. 2000, 13:431-436.
25. De Groof F., Joosten K.F.M., Janssen J.A.M.J.L., et al. Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors. J. Clin. Endocrinol. Metab. 2002, 87:3118-3124.
26. Tasker R.C., Roe M.F.E., Bloxham D.M., White D.K., Ross-Russel R.I., O'Donnel D.R. The neuroendocrine stress response and severity of acute respiratory synsytial virus bronchiolitis in infancy. Intensive Care Med. 2004, 30:2257-2262.
27. Gicquel C., Le Bouc Y. Hormonal regulation of fetal growth. Horm. Res. 2006, 3:28-33.
28. Netchine I., Rossignol S., Dufourg M.N., et al. 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations. J. Clin. Endocrinol. Metab. 2007, 92:3148-3154.
29. Murphy R., Baptista J., Holly J., et al. Severe intrauterine growth retardation and atypical diabetes associated with a translocation breakpoint disrupting regulation of the insulin-like growth factor 2 gene. J. Clin. Endocrinol. Metab. 2008, 93:4373-4380.
30. Binder G., Begemann M., Eggermann T., et al. Silver-Russell syndrome. Best Pract. Res. Clin. Endocrinol. Metab. 2011, 25:153-160.
31. Ghosh P., Dahms N.M., Kornfeld S. Mannose 6-phosphate receptors: new twists in the tale. Nat. Rev. Mol. Cell Biol. 2003, 4:202-212.
32. Brown J., Jones E.Y., Forbes B.E. Interactions of IGF-II with the IGF2R/cation independent mannose-6-phosphate receptor mechanism and biological outcomes. Vitam. Horm. 2009, 80:699-719.
33. Richalet J.P., Leturnel M., Souberbielle J.C. Effects on high-altitude hypoxia on the hormonal response to hypothalamic factors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299:R1685-R1692.
34. Maures T.J., Duan C. Structure, developmental expression, and physiological regulation of zebrafish IGF binding protein-1. Endocrinology 2002, 143:2722-2731.
35. Tazuke S.I., Mazure N.M., Sugawara J., et al. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:10188-10193.
36. Kajimura S., Aida K., Duan C. Understanding hypoxia-induced gene expression in early development: in vitro and in vivo analysis of hypoxia-inducible factor 1-regulated Zebra fish insulin-like growth factor binding protein 1 gene expression. Mol. Cell. Biol. 2006, 26:1142-1155.
37. Murray I.A., Perdew G.H. Omeprazole stimulates the induction of human insulin-like growth factor binding protein-1 through aryl hydrocarbon receptor activation. J. Pharmacol. Exp. Ther. 2008, 324:1102-1110.
38. Bohula E.A., Playford M.P., Macaulay V.M. Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment. Anticancer Drugs 2003, 14:669-682.
39. Peretz S., Kim C., Rockwell S., Baserga R., Glazer P.M. IGF1 receptor expression protects against microenvironmental stress found in the solid tumor. Radiat. Res. 2002, 158:174-180.
40. S.L.S., Milani, Clinic and Laboratory characteristic of Children and adolescents with partial GH and IGF-I insensitivity. PhD thesis, Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo; Ribeirão Preto (2009) 1-113.
41. Kooijman R., Willems M., De Haas C.J.C., et al. Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinology 1992, 131:2244-2250.
42. Segretin M.E., Galeano A., Roldán A., Schillaci R. Insulin-like growth factor-1 receptor regulation in activated human T lymphocytes. Horm. Res. 2003, 59:276-280.